Fundraising Fox
🦊/Companies
Sign in

Spot Biosystems

4 known investors

Find your way into Spot Biosystems

Spot Biosystems is a clinical-stage biopharmaceutical company developing non-viral gene therapies using extracellular vesicles as a delivery method. The company targets genetic diseases including muscular dystrophy and cardiac conditions.

BiotechDigital HealthMedical Devices

Investors · 4

Saltagen VenturesHong Kong
Advantech CapitalreportedCamana Bay
IDG CapitalreportedHong Kong · $3M – $200M
LDV PartnersreportedPalo Alto

In the news

Spot Biosystems Launches with $40 Million Funding and Breakthrough Non-Viral Gene Therapy for DMDbio-itworld.com · Jun 2026Spot Biosystems Delivers Full-Length Dystrophinallsci.com · Jun 2026Spot Biosystems Launches with $40 Million Financing and World-First Non-Viral Delivery of Full-Length Dystrophin in Animal Models and Human Patients with DMD - Las Vegas Sun Newslasvegassun.com · Jun 2026Updated: Spot Bio launches with $40M to study non-viral gene therapy for muscular dystrophyendpoints.news · Jun 2026

Frequently asked questions

What does Spot Biosystems do?
Spot Biosystems is a clinical-stage biopharmaceutical company developing non-viral gene therapies using extracellular vesicles as a delivery method. The company targets genetic diseases including muscular dystrophy and cardiac conditions.
Who are Spot Biosystems's investors?
Spot Biosystems's investors include Saltagen Ventures, Advantech Capital, IDG Capital, LDV Partners.